Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders

Abstract Motor neuron disorders (MND) include a group of pathologies that affect upper and/or lower motor neurons. Among them, amyotrophic lateral sclerosis (ALS) is characterized by progressive muscle weakness, with fatal outcomes only in a few years after diagnosis. On the other hand, primary late...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Estela Area-Gomez, D. Larrea, T. Yun, Y. Xu, J. Hupf, F. Zandkarimi, R. B. Chan, H. Mitsumoto
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d9ac3cd69e5d4df1afc469dd47aa55ca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9ac3cd69e5d4df1afc469dd47aa55ca
record_format dspace
spelling oai:doaj.org-article:d9ac3cd69e5d4df1afc469dd47aa55ca2021-12-02T16:32:08ZLipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders10.1038/s41598-021-92112-32045-2322https://doaj.org/article/d9ac3cd69e5d4df1afc469dd47aa55ca2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92112-3https://doaj.org/toc/2045-2322Abstract Motor neuron disorders (MND) include a group of pathologies that affect upper and/or lower motor neurons. Among them, amyotrophic lateral sclerosis (ALS) is characterized by progressive muscle weakness, with fatal outcomes only in a few years after diagnosis. On the other hand, primary lateral sclerosis (PLS), a more benign form of MND that only affects upper motor neurons, results in life-long progressive motor dysfunction. Although the outcomes are quite different, ALS and PLS present with similar symptoms at disease onset, to the degree that both disorders could be considered part of a continuum. These similarities and the lack of reliable biomarkers often result in delays in accurate diagnosis and/or treatment. In the nervous system, lipids exert a wide variety of functions, including roles in cell structure, synaptic transmission, and multiple metabolic processes. Thus, the study of the absolute and relative concentrations of a subset of lipids in human pathology can shed light into these cellular processes and unravel alterations in one or more pathways. In here, we report the lipid composition of longitudinal plasma samples from ALS and PLS patients initially, and after 2 years following enrollment in a clinical study. Our analysis revealed common aspects of these pathologies suggesting that, from the lipidomics point of view, PLS and ALS behave as part of a continuum of motor neuron disorders.Estela Area-GomezD. LarreaT. YunY. XuJ. HupfF. ZandkarimiR. B. ChanH. MitsumotoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Estela Area-Gomez
D. Larrea
T. Yun
Y. Xu
J. Hupf
F. Zandkarimi
R. B. Chan
H. Mitsumoto
Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
description Abstract Motor neuron disorders (MND) include a group of pathologies that affect upper and/or lower motor neurons. Among them, amyotrophic lateral sclerosis (ALS) is characterized by progressive muscle weakness, with fatal outcomes only in a few years after diagnosis. On the other hand, primary lateral sclerosis (PLS), a more benign form of MND that only affects upper motor neurons, results in life-long progressive motor dysfunction. Although the outcomes are quite different, ALS and PLS present with similar symptoms at disease onset, to the degree that both disorders could be considered part of a continuum. These similarities and the lack of reliable biomarkers often result in delays in accurate diagnosis and/or treatment. In the nervous system, lipids exert a wide variety of functions, including roles in cell structure, synaptic transmission, and multiple metabolic processes. Thus, the study of the absolute and relative concentrations of a subset of lipids in human pathology can shed light into these cellular processes and unravel alterations in one or more pathways. In here, we report the lipid composition of longitudinal plasma samples from ALS and PLS patients initially, and after 2 years following enrollment in a clinical study. Our analysis revealed common aspects of these pathologies suggesting that, from the lipidomics point of view, PLS and ALS behave as part of a continuum of motor neuron disorders.
format article
author Estela Area-Gomez
D. Larrea
T. Yun
Y. Xu
J. Hupf
F. Zandkarimi
R. B. Chan
H. Mitsumoto
author_facet Estela Area-Gomez
D. Larrea
T. Yun
Y. Xu
J. Hupf
F. Zandkarimi
R. B. Chan
H. Mitsumoto
author_sort Estela Area-Gomez
title Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
title_short Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
title_full Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
title_fullStr Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
title_full_unstemmed Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
title_sort lipidomics study of plasma from patients suggest that als and pls are part of a continuum of motor neuron disorders
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d9ac3cd69e5d4df1afc469dd47aa55ca
work_keys_str_mv AT estelaareagomez lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT dlarrea lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT tyun lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT yxu lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT jhupf lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT fzandkarimi lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT rbchan lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
AT hmitsumoto lipidomicsstudyofplasmafrompatientssuggestthatalsandplsarepartofacontinuumofmotorneurondisorders
_version_ 1718383839682756608